Short- and Long-Term Self-Reported Symptoms in Adolescents Aged 12–19 Years after Vaccination against SARS-CoV-2 Compared to Adolescents Not Vaccinated—A Danish Retrospective Cohort Study

This study investigated self-reported short- and long-term symptoms among adolescents receiving the BNT162b2 (Pfizer/BioNTech) vaccine against SARS-CoV-2 and those who did not. A retrospective cohort study based on Danish national survey (collected between 20 July and 15 September 2021) and register...

Full description

Bibliographic Details
Main Authors: Selina Kikkenborg Berg, Helle Wallach-Kildemoes, Line Ryberg Rasmussen, Ulrikka Nygaard, Henning Bundgaard, Maria Nivi Schmidt Petersen, Cecilie Bech Hammer, Annette Kjær Ersbøll, Lau Caspar Thygesen, Susanne Dam Nielsen, Anne Vinggaard Christensen
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/10/11/1863
_version_ 1797466319654748160
author Selina Kikkenborg Berg
Helle Wallach-Kildemoes
Line Ryberg Rasmussen
Ulrikka Nygaard
Henning Bundgaard
Maria Nivi Schmidt Petersen
Cecilie Bech Hammer
Annette Kjær Ersbøll
Lau Caspar Thygesen
Susanne Dam Nielsen
Anne Vinggaard Christensen
author_facet Selina Kikkenborg Berg
Helle Wallach-Kildemoes
Line Ryberg Rasmussen
Ulrikka Nygaard
Henning Bundgaard
Maria Nivi Schmidt Petersen
Cecilie Bech Hammer
Annette Kjær Ersbøll
Lau Caspar Thygesen
Susanne Dam Nielsen
Anne Vinggaard Christensen
author_sort Selina Kikkenborg Berg
collection DOAJ
description This study investigated self-reported short- and long-term symptoms among adolescents receiving the BNT162b2 (Pfizer/BioNTech) vaccine against SARS-CoV-2 and those who did not. A retrospective cohort study based on Danish national survey (collected between 20 July and 15 September 2021) and register data was conducted. Differences in short-term (<14 days) and long-term (>two months) symptoms were explored using logistic regression adjusted for confounders. A total of 747 vaccinated (first dose n = 326; second dose n = 421) and 6300 unvaccinated adolescents were included in analyses of short-term symptoms and 32 vaccinated and 704 unvaccinated adolescents in long-term symptom analyses. In the first 14 days after the first and second vaccine dose the most reported symptoms included headache and muscle or joint symptoms. In both vaccinated and unvaccinated adolescents, the 15–19-year-olds reported significantly higher proportions of all symptoms compared to the 12–14-year-olds. After the second vaccine dose vaccinated 12–14-year-olds reported significantly more headache in adjusted analyses (OR 2.20 (95% CI 1.24; 3.90)). Among the 15–19-year-olds, significantly more vaccinated adolescents reported gastrointestinal symptoms (1.38 (1.06; 1.81)), headache (1.66 (1.24; 2.22)), and tiredness (1.44 (1.08; 1.93)). No differences were found in long-term symptoms. Vaccinated adolescents reported significantly more short-term symptoms including headache, tiredness, and gastrointestinal symptoms after the second vaccine dose than unvaccinated adolescents. Long-term symptom results should be interpreted with caution due to limited sample size.
first_indexed 2024-03-09T18:34:11Z
format Article
id doaj.art-64468dc141d74da38face2a27091682c
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-09T18:34:11Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-64468dc141d74da38face2a27091682c2023-11-24T07:13:53ZengMDPI AGVaccines2076-393X2022-11-011011186310.3390/vaccines10111863Short- and Long-Term Self-Reported Symptoms in Adolescents Aged 12–19 Years after Vaccination against SARS-CoV-2 Compared to Adolescents Not Vaccinated—A Danish Retrospective Cohort StudySelina Kikkenborg Berg0Helle Wallach-Kildemoes1Line Ryberg Rasmussen2Ulrikka Nygaard3Henning Bundgaard4Maria Nivi Schmidt Petersen5Cecilie Bech Hammer6Annette Kjær Ersbøll7Lau Caspar Thygesen8Susanne Dam Nielsen9Anne Vinggaard Christensen10Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Inge Lehmanns Vej 7, 2100 Copenhagen, DenmarkDepartment of Cardiology, Rigshospitalet, Copenhagen University Hospital, Inge Lehmanns Vej 7, 2100 Copenhagen, DenmarkDepartment of Cardiology, Rigshospitalet, Copenhagen University Hospital, Inge Lehmanns Vej 7, 2100 Copenhagen, DenmarkFaculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, DenmarkDepartment of Cardiology, Rigshospitalet, Copenhagen University Hospital, Inge Lehmanns Vej 7, 2100 Copenhagen, DenmarkNational Institute of Public Health, University of Southern Denmark, Studiestræde 6, 1455 Copenhagen, DenmarkDepartment of Cardiology, Rigshospitalet, Copenhagen University Hospital, Inge Lehmanns Vej 7, 2100 Copenhagen, DenmarkNational Institute of Public Health, University of Southern Denmark, Studiestræde 6, 1455 Copenhagen, DenmarkNational Institute of Public Health, University of Southern Denmark, Studiestræde 6, 1455 Copenhagen, DenmarkFaculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, DenmarkDepartment of Cardiology, Rigshospitalet, Copenhagen University Hospital, Inge Lehmanns Vej 7, 2100 Copenhagen, DenmarkThis study investigated self-reported short- and long-term symptoms among adolescents receiving the BNT162b2 (Pfizer/BioNTech) vaccine against SARS-CoV-2 and those who did not. A retrospective cohort study based on Danish national survey (collected between 20 July and 15 September 2021) and register data was conducted. Differences in short-term (<14 days) and long-term (>two months) symptoms were explored using logistic regression adjusted for confounders. A total of 747 vaccinated (first dose n = 326; second dose n = 421) and 6300 unvaccinated adolescents were included in analyses of short-term symptoms and 32 vaccinated and 704 unvaccinated adolescents in long-term symptom analyses. In the first 14 days after the first and second vaccine dose the most reported symptoms included headache and muscle or joint symptoms. In both vaccinated and unvaccinated adolescents, the 15–19-year-olds reported significantly higher proportions of all symptoms compared to the 12–14-year-olds. After the second vaccine dose vaccinated 12–14-year-olds reported significantly more headache in adjusted analyses (OR 2.20 (95% CI 1.24; 3.90)). Among the 15–19-year-olds, significantly more vaccinated adolescents reported gastrointestinal symptoms (1.38 (1.06; 1.81)), headache (1.66 (1.24; 2.22)), and tiredness (1.44 (1.08; 1.93)). No differences were found in long-term symptoms. Vaccinated adolescents reported significantly more short-term symptoms including headache, tiredness, and gastrointestinal symptoms after the second vaccine dose than unvaccinated adolescents. Long-term symptom results should be interpreted with caution due to limited sample size.https://www.mdpi.com/2076-393X/10/11/1863COVID-19vaccineBNT162b2adolescentsside effects
spellingShingle Selina Kikkenborg Berg
Helle Wallach-Kildemoes
Line Ryberg Rasmussen
Ulrikka Nygaard
Henning Bundgaard
Maria Nivi Schmidt Petersen
Cecilie Bech Hammer
Annette Kjær Ersbøll
Lau Caspar Thygesen
Susanne Dam Nielsen
Anne Vinggaard Christensen
Short- and Long-Term Self-Reported Symptoms in Adolescents Aged 12–19 Years after Vaccination against SARS-CoV-2 Compared to Adolescents Not Vaccinated—A Danish Retrospective Cohort Study
Vaccines
COVID-19
vaccine
BNT162b2
adolescents
side effects
title Short- and Long-Term Self-Reported Symptoms in Adolescents Aged 12–19 Years after Vaccination against SARS-CoV-2 Compared to Adolescents Not Vaccinated—A Danish Retrospective Cohort Study
title_full Short- and Long-Term Self-Reported Symptoms in Adolescents Aged 12–19 Years after Vaccination against SARS-CoV-2 Compared to Adolescents Not Vaccinated—A Danish Retrospective Cohort Study
title_fullStr Short- and Long-Term Self-Reported Symptoms in Adolescents Aged 12–19 Years after Vaccination against SARS-CoV-2 Compared to Adolescents Not Vaccinated—A Danish Retrospective Cohort Study
title_full_unstemmed Short- and Long-Term Self-Reported Symptoms in Adolescents Aged 12–19 Years after Vaccination against SARS-CoV-2 Compared to Adolescents Not Vaccinated—A Danish Retrospective Cohort Study
title_short Short- and Long-Term Self-Reported Symptoms in Adolescents Aged 12–19 Years after Vaccination against SARS-CoV-2 Compared to Adolescents Not Vaccinated—A Danish Retrospective Cohort Study
title_sort short and long term self reported symptoms in adolescents aged 12 19 years after vaccination against sars cov 2 compared to adolescents not vaccinated a danish retrospective cohort study
topic COVID-19
vaccine
BNT162b2
adolescents
side effects
url https://www.mdpi.com/2076-393X/10/11/1863
work_keys_str_mv AT selinakikkenborgberg shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy
AT hellewallachkildemoes shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy
AT linerybergrasmussen shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy
AT ulrikkanygaard shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy
AT henningbundgaard shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy
AT marianivischmidtpetersen shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy
AT ceciliebechhammer shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy
AT annettekjærersbøll shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy
AT laucasparthygesen shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy
AT susannedamnielsen shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy
AT annevinggaardchristensen shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy